Heart diseases are major causes of morbidity and mortality linked to extensive loss of cardiac cells. Embryonic stem cells (ESCs) give rise to cardiomyocyte-like cells, which may be used in heart cell replacement therapies. Most cardiogenic differentiation protocols involve the culture of ESCs as embryoid bodies (EBs). Stirred-suspension bioreactor cultures of ESC aggregates may be employed for scaling up the production of cardiomyocyte progeny but the wide range of EB sizes and the unknown effects of the hydrodynamic environment on differentiating EBs are some of the major challenges in tightly controlling the differentiation outcome. Here, we explored the cardiogenic potential of mouse ESCs (mESCs) and human ESCs (hESCs) encapsulated in poly-L-lysine (pLL)-coated alginate capsules. Liquefaction of the capsule core led to the formation of single ESC aggregates within each bead and their average size depended on the concentration of seeded ESCs. Encapsulated mESCs were directed along cardiomyogenic lineages in dishes under serumfree conditions with the addition of bone morphogenetic protein 4 (BMP4). Human ESCs in pLL-layered liquid core (LC) alginate beads were also differentiated towards heart cells in serum-containing media. Besides the robust cell proliferation, higher fractions of cells expressing cardiac markers were detected in ESCs encapsulated in LC than in solid beads. Furthermore, we demonstrated for the first time that ESCs encapsulated in pLL-layered LC alginate beads can be coaxed towards heart cells in stirred-suspension bioreactors. Encapsulated ESCs yielded higher fractions of Nkx2.5-and GATA4-positive cells in the bioreactor compared to dish cultures. Differentiated cells formed beating foci that responded to chronotropic agents in an organotypic manner. Our findings warrant further development and implementation of microencapsulation technologies in conjunction with bioreactor cultivation to enable the production of stem cellderived cardiac cells appropriate for clinical therapies and applications.
INTRODUCTION
surfaces (21, 49) . These systems, however, yield EBs with large variations in size, contributing to the heterogeneity of the differentiated cells. Heart disease is associated with extensive cardiomyocyte attrition and impaired heart function, leading to Several studies have linked the EB size to stem cell fate decisions, including the adoption of a cardiac cell high morbidity and mortality (38) . Given the scarcity of donor organs for transplantation, cardiac cell replace-phenotype (6, 24) . Various methods have been proposed for generating EBs of specific size, including centrifuga-ment therapy has emerged as an appealing alternative, fueling efforts into renewable sources of functional tion in 96-well plates (34) , seeding in 3D microwells with defined geometric size (20, 31) , and micropatterned cardiomyocytes. Embryonic stem cells (ESCs) give rise to cardiomyocyte-like cells, which reverse heart injury surfaces (41) . These systems allow extensive and precise control of the stem cell niche and are suitable for study-in rodents (50) after implantation. To date, most protocols for in vitro cardiogenic differentiation of ESCs ing the effect of EB size on the differentiation outcome. Yet, most of them are challenging to scale up for pro-entail the formation of multicellular aggregates or embryoid bodies (EBs) (13, 21) . Typically, EBs are gener-ducing EBs with uniform size and in sufficient amounts for seeding commercial-scale bioreactors. ated by the hanging drop method, methylcellulose culture, or spontaneous aggregation of ESCs on low-adhesion Reports of ESC differentiation as EBs to heart cells 1398 JING, PARIKH, AND TZANAKAKIS in stirred-suspension vessels serve as a proof of princi-ever, these capsules have reduced mechanical stability, making them unsuitable for culture in bioreactors under ple that such bioreactors can be used for the production of medically relevant quantities of heart cells. The scala-constant stirring. Furthermore, the ability of ESCs encapsulated in alginate beads to give rise to heart cell bility of EB formation in petri dishes (51) prior to their inoculation in spinner flasks is limited and the resulting progeny has not been analyzed in detail.
Here, we explored the cardiogenic potential of EBs are uneven in size. When single, dispersed mouse ESCs (mESCs) are loaded in a stirred-suspension bio-mESCs and human ESCs (hESCs) encapsulated in alginate beads coated with poly-L-lysine (pLL) (23). We hy-reactor (42) EBs are formed, but their size and concentration depend largely on the agitation rate. Low stirring pothesized that aggregates with specific size can be formed by encapsulating ESCs in pLL-coated capsules speeds result in a few oversized aggregates exhibiting poor cell growth, whereas more intense agitation in-and dissolving their core. Indeed, liquefaction of the core allowed the formation of a single ESC aggregate duces high shear, affecting cell viability, morphology, gene expression, and the differentiation potential of per bead and its size was adjusted via the ESC seeding density. The cardiogenic differentiation of encapsulated ESCs, as shown also in rotary orbital cultures (40) .
To that end, Niebruegge et al. (35) reported that ESCs was directed with a physiologically relevant factor under serum-free conditions as well as in serum-supple-hESC colonies from micropatterned slides inoculated in spinner flasks with serum-containing medium lead to the mented media. Most importantly, encapsulated mESCs and hESCs cultured in spinner flasks also gave rise to emergence of cells expressing cardiac cell genes after 2 weeks of culture. Among the different pattern sizes heart cell phenotypes with higher efficiency compared to their static culture counterparts. Our results support examined, EBs from 400-µm microprints exhibit the highest cell proliferation and yield of heart cells. Besides further development of this culture modality for the scalable differentiation of stem cells to therapeutically use-the intimate link between EB size and cardiogenic differentiation, these findings show that coupling methods ful cells such as cardiomyocytes. for generating particular size EBs to bioreactor cultures MATERIALS AND METHODS enhances significantly the differentiation of ESCs to Human Embryonic Stem Cell Culture heart cells. Given the practical considerations stemming from loading large-scale bioreactors with cells from mi-Human H9 ESCs (WiCell Research Institute, Madicropatterned slides, alternative methods may be more atson, WI) were maintained as described previously (27) . tractive.
Briefly, hESCs were cultured on mitomycin C-treated One such approach is the encapsulation of stem cells (Sigma-Aldrich, St. Louis, MO) mouse embryonic fibroprior to their differentiation in stirred-suspension vessels blasts (mEFs) in Dulbecco's modified Eagle's medium/ to heart cells. Hydrogels such as agarose (5) , dextran
Ham's F-12 medium (DMEM/F12) with 20% KnockOut (15), and gelatin (1) have been used for culturing ESCs. serum replacement (KSR), 2 mM L-glutamine, 1 mM Alginate (19, 29, 30) remains the encapsulation material nonessential amino acids, 100 U/ml penicillin and 100 of choice because of its intrinsic properties (36), includmg/ml streptomycin, and 4 ng/ml basic fibroblast growth ing biocompatibility, biosafety, adjustable permeability, factor (bFGF; all from Invitrogen, Carlsbad, CA). and the benign conditions employed during its prepara-For differentiation experiments, the cells were maintion (e.g., physiological temperature and the lack of cytained free of mEFs on dishes coated with growth factortotoxic solvents). Alginate-based scaffolds have also reduced Matrigel (BD Biosciences, San Jose, CA) for been employed in cardiac tissue engineering (2) . Inter-1-2 passages and in mEF-conditioned medium (CM) estingly enough, various high-throughput designs are (27) . The CM was filter sterilized and supplemented currently available [e.g., electrostatic generator (8), airwith 4 ng/ml bFGF before its addition to hESCs. driven multinozzle droplet generator (12)] for the encap-Cultures were manually passaged every 6-7 days sulation of a wide range of mammalian cells (7, 11, 32) , with 2 mg/ml collagenase IV (GIBCO, Grand Island, even under good manufacturing practice (GMP) condi-NY) in DMEM/F12 and split 1:4-1:6. The cultures were tions (43) . maintained in 5% CO 2 /95% air at 37°C and media were Encapsulation of ESCs in solid alginate beads for difreplaced daily. ferentiation to various lineages (28, 30, 47) 
results in a
Mouse Embryonic Stem Cell Culture dispersed cell phase. As such, encapsulated ESCs have the propensity to form multiple EBs within each bead, mESCs (E14Tg2a; Mutant Mouse Regional Resource Centers, University of California-Davis, CA) were limiting control over their size. Lowering the alginate concentration may increase the internal fluidity of the maintained in tissue culture dishes coated with 0.1% gelatin-phosphate-buffered saline (PBS; Sigma) solution in bead, facilitating the formation of a single EB per bead and the exchange of nutrients through the bead. How-5% CO 2 /95% air at 37°C (22) . The culture medium con-sisted of DMEM (Mediatech, Manassas, VA) with 10% coated beads with a solid core were released by combining steps (i) and (ii) and we noted >95% recovery of ESC-screened FBS (Hyclone, Logan, UT), 2 mM Lglutamine, 0.1 mM nonessential amino acids, 0.055 mM live cells. Cell release from the beads was confirmed by observation under a microscope. Aggregate dissociation β-mercaptoethanol, penicillin (100 U/ml), streptomycin (100 µg/ml), and 1,000 U/ml leukemia inhibitor factor into single cells was described previously (22) . (LIF; Chemicon, Temecula, CA). This medium is Differentiation of ESCs termed serum-containing mESC medium (SCMM). Medium was replaced every day and the mESCs were pas-Single dispersed hESCs pretreated with 10 µM Y27632 were seeded in petri dishes and formed EBs in saged every 2-3 days by incubation with TrypLE (GIBCO) and gentle pipetting to dissociate clumps into differentiation medium consisting of KnockOut-DMEM (KO-DMEM; Invitrogen), 1 mM L-glutamine, 0.1 mM single cells. For the experiments performed in this study, mESCs were adapted in defined serum-free medium β-mercaptoethanol, 1% nonessential amino acids, and 20% FBS (Hyclone, Logan, UT). Cells were incubated (DSFM) over 6-10 passages (22) . The composition of DSFM is similar to that of SCMM above except that with differentiation medium for up to 2 weeks. mESCs were cultured as monolayers or EBs in 10% KSR is added instead of FBS.
SCMM with conventional FBS instead of ESC-screened Cell Encapsulation and Release
FBS and without LIF. All-trans retinoic acid (RA, 1 nM; Sigma) was added as stated. For serum-free differentia-For encapsulation experiments, undifferentiated hESC colonies were incubated with 10 µM Y27632 [a Rho-tion, the EBs were cultured in DSFM without LIF (DSFM-L) supplemented with 10 ng/ml recombinant associated protein kinase (ROCK) inhibitor (EMD, Gibbstown, NJ)] for 1 h prior to their dissociation into bone morphogenetic protein 4 (BMP4) (R&D Systems, Minneapolis, MN) for the first 6 days of differentiation. single hESCs upon treatment with Accutase (Millipore, Billerica, MA). Mouse ESCs were harvested as single Then, cells were maintained in DSFM-L alone. Medium was changed every 2 days. cells as described above. The cells were counted in a hemocytometer and resuspended in sterile sodium algi-Encapsulated mESCs and hESCs were coaxed towards the cardiomyogenic lineage using the same dif-nate (FMC Biopolymer, Philadelphia, PA) solution in DMEM at room temperature, resulting in densities of ferentiation media and time of incubation as for their nonencapsulated counterparts. At different times, the ag-10 5 -10 7 cells/ml and 1.5% final alginate concentration. Beads were generated by passing the cell/alginate solu-gregates were released from the beads for further analysis. tion through a 27-gauge syringe needle coaxially with an air jet (25) into a sterile 100 mM CaCl 2 solution.
The aggregates were transferred to gelatin-coated plates at ϳ1-3 EBs/cm 2 for hESCs and ϳ4-6 EBs/cm 2 The airflow was adjusted so as to produce beads with a 500-600-µm diameter. After a 5-min incubation in for mESCs. Spontaneously beating foci emerged as early as 2 days after plating. CaCl 2 , the beads were washed twice with basal medium and immersed into 0.05% (w/v) pLL solution (Sigma)
Bioreactor Culture and Sampling for 2 min. The core was liquefied by incubating the beads in 0.055 M sodium citrate solution (a Ca 2+ chela-Encapsulated ESCs were seeded in 125 ml ProCulture spinner flasks (Corning, Corning, NY) at 2 × 10 4 tor) for 5 min followed by washing twice with culture medium. To assess the viability of cells immediately cells/ml. The agitation rate was kept constant at 45 rpm throughout each run. Encapsulated mESCs in spinner after their encapsulation, the beads were incubated with 20 µg/ml fluorescein diacetate (FDA; live cells) and 10 flasks were incubated with DSFM-L containing 10 ng/ ml BMP4 for 6 days followed by DSFM-L alone. Cap-µg/ml propidium iodide (PI; dead cells; both from Sigma) in PBS for 5-15 min (27) . The beads were sules with hESCs in stirred suspension were incubated in the same serum-supplemented differentiation medium washed three times with PBS and observed on a fluorescence inverted microscope.
as described for static hESC cultures. Media were replaced every 2 days. Samples (ϳ0.5 ml) were with-Encapsulated cells were released from beads as follows: (i) pLL-coated beads with a liquefied core were drawn from spinner flasks under continuous stirring to ensure that similar numbers of beads per unit volume of incubated with TrypLE (which is formulated in Dulbecco's PBS with 1 mM EDTA) for 5 min at room tempera-medium were collected each time. Samples were obtained every 1-2 days and an equal amount of fresh ture. Breakage of the beads was facilitated by gentle pipetting using 1000-µl pipette tips as reported (16). (ii) medium was added to keep the total culture volume constant. After acquiring images of cell-laden beads, encap-Solid beads were incubated with 0.055 M sodium citrate solution for 5 min and the cells were washed with cul-sulated cells were released, stained with the trypan blue dye (GIBCO), and counted in a hemocytometer. ture medium and centrifuged twice. (iii) Cells in pLL-
Image Analysis
Real-time polymerase chain reactions were performed on an iCycler quantitative PCR (qPCR) machine Samples were transferred to dishes and examined un-(Bio-Rad, Hercules, CA) with the DyNAmo SYBR der an inverted microscope. Images of the beads were Green qPCR mix (Finnzymes, Woburn, MA) under the acquired via a Nikon digital camera connected to the following conditions: denaturation and polymerase actimicroscope and analyzed with the NIH ImageJ (http:// vation at 95°C for 2 min; amplification for 40 cycles at rsb.info.nih.gov/ij/). At least 20 images were analyzed 95°C for 15 s, 58°C or 60°C for 30 s, and 72°C for 1 per condition. The diameter of each aggregate or bead min. All reactions were run in triplicate on samples from was calculated by taking the average of two perpendicuat least three experiments. Amplification specificity was lar diameters.
verified by a melting curve method. Relative gene ex-The permeability of pLL-coated alginate beads was pression was calculated using the ∆∆C T method (26) . βdetermined by incubation with a 106 kDa fluorescein Actin was used as the housekeeping gene and its C T did isothiocyanate conjugated-immunoglobulin (IgG-FITC;
not vary under different experimental conditions when Jackson ImmunoResearch Laboratories, West Grove, equal amounts of RNA were used. PCR efficiencies for PA) and observation under a Zeiss Axio Observer Z1 different primer pairs were ϳ1 as determined by a stanfluorescence microscope (Carl Zeiss, Thornwood, NY) dard curve method on serially diluted templates. at different times. Transmission and green fluorescence images were acquired at the equatorial plane of the Immunocytochemistry beads with the AxioVision software and the correspond-Cells were washed in PBS and fixed with 4% paraing fluorescence intensity profiles were generated in formaldehyde (Sigma) in PBS for 20 min at room tem-MATLAB (The MathWorks, Natick, MA) using the surf perature (22) . After washing with PBS, cells were perand contour functions. Sigma). After three 5-min washes with PBS, the samples Analysis of LDH activity in supernatant samples was were incubated with secondary antibodies for 1 h at carried out with a LDH-based cytotoxicity detection kit room temperature. Donkey anti-rabbit, anti-goat, and (Roche) as we described previously (22) . Calibration anti-mouse secondary antibodies conjugated with FITC curves to convert absorbance to activity units (U/ml) or Cy3 (Jackson ImmunoResearch Laboratories) were were generated using bovine LDH (Sigma) and human used. Nuclear DNA was stained with DAPI (Sigma). LDH (Cell Sciences, Canton, MA) for mESCs and Samples were viewed with a Zeiss Axio Observer Z1 hESCs, respectively. The specific rate of LDH release fluorescence microscope. was calculated by normalizing the LDH activity (U/ml) detected at each interval with the corresponding loga-Flow Cytometry rithmic mean of the viable cell concentration.
Cells were prepared for and analyzed by flow cytom-RNA Extraction, RT-PCR, and Quantitative etry as we reported previously (27) . Cells were fixed PCR (qPCR) for 10 min with 3.7% formaldehyde solution (Sigma-Aldrich), washed with PBS, and blocked with 3% nor-Total RNA was isolated from cells using Trizol (Invitrogen) according to the manufacturer's instructions.
mal donkey serum (NDS) for 30 min. The samples were incubated with the primary antibodies rabbit anti-Reverse transcription was performed using the ImProm-II reverse transcriptase (Promega, Madison, WI) with 1 GATA4 and anti-Nkx2.5 for 1 h at room temperature in 1% NDS. Cells were washed three times with 1% NDS µg of total RNA and 250 ng random primers or oligo(dT) 12-18 primers (Fermentas, Glen Burnie, MD). Re-and incubated with appropriate Cy3-or FITC-conjugated donkey secondary antibodies for 30 min at room verse transcription was carried out at 42°C for 60 min. PCR runs were performed with the resulting comple-temperature. The cells were washed again three times and analyzed with a FACS Calibur flow cytometer with mentary DNA for 35-40 cycles at an annealing temperature of 58-60°C depending on the primer set. Primer the Cell Quest software (Becton Dickinson, Franklin Lakes, NJ). Undifferentiated mESCs and hESCs were sequences are shown in Table 1 . used as negative controls and the mouse cardiac cell line liferation was considerably retarded within the solid beads ( Fig. 1B-D) . Lowering the concentration of algi-HL-1 (10) served as a positive control to confirm gatings. Cells were registered as positive for a particular nate resulted repeatedly in compromised capsule structure and cells leaked out of the beads (Fig. 1E ). Increas-antigen if their emitted fluorescence level was higher than 99% of that of cells stained only with the corre-ing the concentration of alginate helped to avert cell leakage but this affects adversely the viability and pro-sponding secondary antibodies. liferation of encapsulated cells (47) .
Statistical Analysis
These observations prompted us to coat the alginate capsules with pLL. This not only improved the structural Data are expressed as mean ± SD unless stated otherwise. ANOVA and the post-hoc Tukey test were per-integrity of the beads but also allowed the reduction of alginate concentration (≤1.5%). Furthermore, incubation formed using Minitab (Minitab Inc, State College, PA). Values of p < 0.05 were considered as significant.
with a Ca 2+ chelating agent resulted in beads with a liquefied core (LC). This facilitated the formation of single ESC aggregates ( Fig. 1F ). Given the importance of the RESULTS EB size on the differentiation of ESCs, we explored Stem Cell Encapsulation in pLL-Coated Alginate Beads whether the average diameter of aggregates formed in With a Liquefied Core the LC beads could be controlled via an easily adjustable variable such as the seeding cell density. The average Our goal was to examine if ESCs encapsulated in alginate beads can be coaxed towards cardiac cell prog-aggregate diameter was determined 24 h after encapsulation and core liquefaction to allow the completion of eny. Hence, we first explored whether encapsulation in alginate beads affects the viability and proliferation of cluster formation. For hESCs seeded at 10 5 -10 7 cells/ml of alginate solution, the average diameter of the result-ESCs while allowing the formation of aggregates within a certain size range.
ing clusters increased from 31 ± 10 to 411.4 ± 65.4 µm (Fig. 1G) . Similarly, aggregates with a larger average Initially, 10 5 -10 7 dispersed hESCs and mESCs were encapsulated in beads per milliliter of 1-2% (w/v) algi-diameter were observed as the seeding mESC density increased ( Fig. 1H ). nate solution. Generation of beads by the coaxial air jet method did not affect significantly the viability of ESCs An aggregate diameter of ϳ210 µm resulting from H9 hESC colonies on 400-µm patterns was reported as as evidenced by live (FDA)/dead (PI) cell staining ( Fig.  1) . However, the cells remained dispersed and their pro-optimal for cardiac induction (6) . Therefore, for the ex- periments henceforth we chose a seeding density of 5 × given that mESCs in DSFM retain their ability for mesoderm differentiation (22) . To test our hypothesis, mESCs 10 6 H9 hESCs/ml, resulting in an average size of 194 ± 28.8 µm for 1-day-old EBs. The same seeding density were maintained for 8-10 passages in DSFM and cultured for 6 days either as monolayers or EBs in DSFM was selected for mESCs.
Our results show that ESCs can be encapsulated in without LIF (DSFM-L) but supplemented with 10 ng/ml BMP4. Subsequently, BMP4 was withdrawn and the pLL-coated LC alginate beads while maintaining their viability. Cells also proliferated more extensively in LC cells were cultured in DSFM-L alone. The expression of Brachyury (T or Bry) was apparent by day 4, signifying than in solid beads (see Differentiation of Encapsulated mESCs in Serum-free Medium and Cardiogenic Differ-mesendodermal commitment of mESCs ( Fig. 2A) and was downregulated by days 7 and 16, denoting the de-entiation of hESCs below). Moreover, the fluid environment inside the pLL-coated LC capsules allows ESCs to parture from an early mesoderm fate and further maturation (33) . At the same time differentiating mESCs dis-form aggregates and their size can be controlled in a straightforward manner. played a decline in the expression of the pluripotent markers Rex-1 and Nanog (Fig. 2B ) and a marked Serum-Free Cardiogenic Differentiation of mESCs upregulation of cardiomyocyte genes such as α-myosin heavy chain (α-MHC), atrial natriuretic factor (anf), and Our aim was to explore if ESCs in pLL-coated capsules can be coaxed to heart cells via either directed nkx2.5 (Fig. 2C) . The adoption of a cardiac muscle cell fate by the differentiating mESCs was also evident by differentiation or serum-based protocols. For this purpose, we developed a method for guiding the cardiomy-α-actinin immunoreactivity (Fig. 2D ).
Beating was readily seen when EBs were plated in ogenic commitment of mESCs in serum-free medium with physiologically relevant factors. mESCs (22) can tissue culture dishes. In contrast, cells differentiating in monolayer cultures exhibited contractile activity only be adapted and maintained in culture with DSFM, allowing the use of soluble agents (e.g., growth factors) for after being replated at higher densities, promoting the formation of clusters. Contractile foci were not observed differentiation without interference from serum. BMP4 drives mESCs toward heart cells (17) but the necessity when EBs were transferred to plates before day 6. Similarly, beating foci did not appear in mESC clusters cul-for serum activation prior to this differentiation is unsettled (44) . tured in DSFM-L without BMP4. Interestingly enough, outgrowths were noticed in these cultures with morpho-We hypothesized that serum activation is not needed logical resemblances to neuronal-type cells ( Fig. 2E) .
fact that, unlike the serum-based differentiation, the beating outcome in cultures of cells exposed to DSFM-Therefore, allowing cells to form aggregates in conjunction with BMP4 treatment for the first 6 days was neces-L and BMP4 was reproducible in terms of the fraction of beating EBs, time of appearance of the first beating sary for the cardiogenic differentiation of mESCs to proceed and beating activity to emerge. clusters (7-10 days after the start of the differentiation), and time point at which beating reached a maximum More than 90% of the foci exposed to BMP4 exhibited contractile activity 14 days after the differentiation percentage (14-15 days). The effect of BMP4 was abolished when cultured started (Fig. 2F) . In contrast, mESCs coaxed in serumcontaining medium gave rise to less than 40% contrac-cells were treated the BMP antagonist noggin. Beating areas were not observed when the cells were exposed to tile clusters. This increased to ϳ60% with the addition of RA, which is known to enhance the commitment of 150 ng/ml noggin in DSFM-L with 10 ng/ml BMP4. Instead, neuronal-like outgrowths were observed similar mESCs to cardiomyocyte-like cells (48) . Of note is the to those in cultures with DSFM-L alone. Compared to cultured in pLL-coated LC beads with DSFM-L but no BMP4, they did not display cardiac cell proteins. BMP4-treated cells, there was a markedly lower expression of heart muscle genes α-MHC and nkx2.5 in These findings illustrate that mESC encapsulation in pLL-coated LC beads does not hinder the cardiogenic mESCs exposed to noggin (Fig. 2G ). This illustrates the direct role of BMP4 in inducing the cardiomyogenic dif-differentiation using physiologically relevant factors under serum-free conditions. In fact, higher fractions of ferentiation of mESCs. Our results show that BMP4 is sufficient to direct mESCs under serum-free conditions cells positive for cardiac cell markers emerged in LC capsules, which permit cell aggregation. towards cells expressing heart cell markers. Cell aggregation is also important for these cells to exhibit contrac-Cardiogenic Differentiation of hESCs tile activity.
Differentiation of hESCs to cardiomyocytes was car-Differentiation of Encapsulated mESCs ried out in EB cultures with medium containing FBS in Serum-Free Medium (49) . The expression of OCT3/4A and NANOG was reduced during the 2 weeks of hESC differentiation (Fig.  Next, we applied the BMP4-based protocol for directing encapsulated mESCs to cardiac cells. First, however, 4A), whereas cardiac genes such as NKX2.5, GATA4, ANF, αand β-MHC (Fig. 4B) were notably upregu-we examined the permeability of pLL-coated alginate beads to determine whether BMP4 from the medium can lated. Actually, β-MHC was not detectable in hESC monolayers differentiated in the same medium. Yet, the reach the encapsulated cells. For this purpose, LC and nonliquefied core (NLC) pLL-coated beads were incu-expression of β-MHC was pronounced after 14 days of hESC differentiation as EBs. The hESC-derived progeny bated with 10 ng/ml of IgG-FITC (MW ϳ106 kDa) similar to the concentration of BMP4. Diffusion of the IgG-was also immunoreactive to cTnI, Nkx2.5, and GATA4 (data not shown). Spontaneously contracting clusters FITC molecules through the beads was tracked by fluorescence microscopy. Within 1 h after adding the IgG-were first identified after 2 weeks of differentiation and their number increased over time. In addition, treatment FITC, the level of fluorescence was uniform across the interior of both LC and NLC pLL-coated capsules and of hESC-derived beating clusters with IBMX led to a concentration-dependent increase of their contractile ac-did not differ significantly from that outside the beads (Fig. 3A) . Hence, we concluded that diffusion of the tivity (Fig. 4C) . Then, we explored if hESCs in pLL-coated LC and IgG-FITC through the pLL-coated alginate beads is not hindered. Given the lower molecular weight of BMP4 NLC capsules can also be coaxed to cardiac cells in the same serum-based differentiation medium. Cell aggre-(ϳ20-22 kDa as a homodimer) compared to IgG-FITC, we concluded that BMP4 from the medium permeates gates were released from the beads at different times and analyzed. In both LC and NLC capsules, cell viability the beads reaching the cells inside.
Then, mESCs in pLL-coated alginate beads were in-remained high throughout the differentiation. Yet, there was a 9.36 ± 1.42-fold cell expansion in LC beads after cubated in dishes with DSFM-L and 10 ng/ml BMP4. Over 7 days of differentiation, cells in LC beads grew 2 weeks compared to only a 2.69 ± 0.78-fold in solid capsules (Fig. 5A ). 8 ± 0.65-fold compared to 5.2 ± 0.29-fold (p < 0.05) in NLC beads (Fig. 3B ). Under both conditions, the viabil-We subsequently assayed differentiated cells in LC capsules for the expression of cardiac cell markers. Like ity of encapsulated cells remained above 95% (data not shown). Aggregates, released from the LC capsules and their nonencapsulated counterparts, hESCs differentiated in LC beads exhibited a downregulation of OCT3/4A plated, yielded contractile bodies within 2 days. This is the same time frame in which beating bodies appeared and NANOG (Fig. 5B ) and a marked increase in genes such as α-MHC, ANF, NKX2.5, and TBX20 (Fig. 5C ). after plating nonencapsulated, differentiating mESCs. In contrast, no beating bodies were formed by cells re-The induction of cardiogenic differentiation in LC beads was corroborated by immunostaining for markers such leased from NLC capsules. In line with this finding, examination by flow cytometry revealed that ϳ13% of dif-as cTnI and cardiac MHC (Fig. 5D ). Flow cytometry analysis revealed that ϳ32% of cells were Nkx2.5 + and ferentiating cells in LC beads were Nkx2.5 + compared to only ϳ2.5% from NLC beads (Fig. 3C) . The limited a similar fraction was GATA4 + (see Differentiation of Encapsulated ESCs in a Stirred-suspension Bioreactor mESC aggregation in solid beads may have contributed to the absence of beating bodies.
Culture below). Comparison of differentiated populations derived Cells cultured in LC capsules with DSFM-L and BMP4 were immunopositive for cTnT and GATA4 (Fig. from nonencapsulated hESCs and hESCs in pLL-coated LC beads showed 16.57 ± 3.96% and 17.31 ± 3.31% α-3D). Plated cells formed spontaneously contracting clusters and their beating rate was modulated by IBMX in a actinin + /cTnI + cells, respectively (Fig. 5E ). In addition, EBs released from LC beads organized into clusters dis-dose-dependent manner (Fig. 3E) . When mESCs were playing contractile activity, which was accelerated upon ing nonencapsulated mESCs and hESCs in static cultures were implemented. Given the scalability of various exposure to increasing concentrations of IBMX (Fig.  5F ). Thus, encapsulation in alginate capsules and disso-encapsulation methods (12,37), one could envision their use for generating suitable amounts of stem cell-laden lution of the bead core did not affect markedly the cardiogenic differentiation of hESCs induced by serum-beads for seeding commercial-scale bioreactors for the production of therapeutically useful cells. containing medium in dish cultures.
Hence, the question is whether ESCs encapsulated in Differentiation of Encapsulated ESCs pLL-coated LC capsules can be differentiated en masse in a Stirred-Suspension Bioreactor Culture toward heart cells in a stirred-suspension vessel. For this purpose, spinner flasks were inoculated with 2 × 10 4 We showed that the encapsulation of ESCs in pLLcoated LC beads did not hinder their differentiation to cells/ml of mESC-or hESC-laden pLL-coated LC beads. The same differentiation media were used as de-heart cells when the same protocols developed for coax- scribed above (i.e., DSFM-L + BMP4 for mESCs and
The slower growth towards the end of the culture could be attributed to the advanced differentiated state of the medium with FBS for hESCs).
Differentiating mESCs cultured for 1 week grew 5.15 cells given that the encapsulated aggregates did not overgrow the beads in any of our experiments. The cu-± 0.11 times while their viability remained above 90% (Fig. 6A) . The cumulative LDH activity in the medium, mulative LDH activity increased over time but (as for mESCs) did not exceed 2 U/ml (Fig. 7B) . which was also determined as a measure of potential cell lysis, did not exceed 2 U/ml (Fig. 6B) . mESCs with-Cells expressing human cardiomyocyte genes such as α-MHC and TBX20 (Fig. 7C ) emerged at the end of drawn on day 7 from the bioreactor, released from beads, and plated formed beating foci within 2 days, re-the differentiation. When analyzed by flow cytometry, 36.9 ± 0.5% of cells in stirred suspension expressed sponding to IBMX by increasing their contractile activity in a dose-dependent manner (data not shown). These NKX2.5 compared to 32.5 ± 0.7% in plates after 14 days of differentiation ( Fig. 7D) . At the same time, there cells expressed heart cell genes ( Fig. 6C ) and were immunopositive for cTnT ( Fig. 6D) and Nkx2.5 (Fig. 6E) .
were 49 ± 0.2% and 32.7 ± 0.4% GATA4 + cells in the spinner flask and dish cultures, respectively. Thus, the Interestingly, bioreactor cultures yielded a higher fraction of Nkx2.5 + cells compared to encapsulated mESCs fractions of hESC-and mESC-derived cells expressing cardiac cell markers were higher in spinner flasks than differentiated in dishes (Fig. 3C) .
Human ESCs in LC capsules were also coaxed to in dishes. Lastly, beating progeny from encapsulated hESCs heart cells while cultured in spinner flasks with serumcontaining medium. Encapsulated hESCs cultured in differentiated in the bioreactor responded to chronotropic agents in an organotypic manner. Incubation of spinner flasks with differentiation medium expanded 8.52 ± 0.89-fold in 15 days with >85% viability (Fig. 7) .
beating bodies with increasing concentrations of IBMX resulted in acceleration of their contractile rate (Fig. 7E) , genic differentiation of mESCs and hESCs. We provide a first account of ESC differentiation in pLL-coated LC whereas diltiazem, a Ca 2+ channel blocker, had the opposite effect (Fig. 7F) .
alginate beads towards heart cell progeny. Encapsulation of ESCs in these microcapsules does not affect cell via-Thus, the cardiogenic differentiation of ESCs in pLLcoated LC capsules cultured in bioreactors is shown for bility, and aggregates of particular size can be obtained by adjusting the seeded ESC density. We showed that the first time. Cells were coaxed in serum-free medium with a physiologically relevant factor (BMP4; for stem cells in alginate beads can be directed to heart cells either under serum-free conditions with physiologically mESCs) as well as in FBS-containing medium (nonspecific differentiation; for hESCs) yielded higher fractions relevant factors or in serum-supplemented medium. More importantly, this is the first report of successful of cells expressing heart cell-specific markers in a bioreactor than in dishes. Therefore, the system described cardiogenic differentiation of hESCs and mESCs in pLL-coated LC alginate beads cultured in scalable here is promising for the production of cardiomyocytes from stem cells for therapies. stirred-suspension vessels. Our findings collectively show that processes combining encapsulation of human DISCUSSION stem cells in alginate beads, liquefaction of the capsule core, and culture in bioreactors may be employed for In this study, we investigated a 3D culture system based on alginate microencapsulation for the cardio-generating cells in therapeutically suitable quantities. Previously, ESCs were coaxed to heart cell progeny sufficient quantities of EBs/cells on slides for loading bioreactors for commercial production. Moreover, the in stirred-suspension bioreactor cultures with the formation of EBs either in low-adhesion surfaces (1, 5) or via cost associated with the fabrication of micropatterned surfaces with an extended area for large scale cell culti-agitation of single dispersed mESCs (42) . While the former method of generating EBs is hardly scalable and vation can be considerable. Nonetheless, results in these studies demonstrate the results in a wide distribution of EB sizes, the latter raises concerns about the effects of agitation-induced shear on importance of aggregate size on the cardiogenic differentiation of ESCs. To that end, other methods have also the viability of ESCs and their ability for differentiation. Moreover, our experience has been that control of the been developed to control the EB size including forced aggregation/centrifugation in 96-well plates and seeding ESC aggregate size in spinner flasks via agitation alone is challenging. More recently, hESC differentiation to in 3D microwells (20, 31, 34) , which allow for the precise manipulation of the stem cell microenvironment. heart cells was achieved by inoculating spinner flasks with EBs generated after harvesting specific size hESC
We chose to control the aggregate size by seeding ESCs at specific densities in pLL-coated alginate beads colonies from micropatterned surfaces (35) . There may be practical considerations regarding the preparation of with diameters between 500 and 600 µm and liquefying the bead core. This approach is advantageous for gener-reactor. Fourth, the cost of employing cell microencapsulation technologies compares favorably to that of other ating stem cell aggregates of relatively uniform size intended for culture in stirred-suspension bioreactors. methods requiring, for example, microfabrication. This makes cell encapsulation economically attractive for use First, large quantities of cells can be processed and microcapsules can be generated in numbers that are suffi-in commercial-scale bioprocesses. Fifth, the bead interior provides a microenvironment that is protected from cient to load large-scale bioreactors. For example, 2 × 10 6 mouse fibroblasts/ml can be encapsulated in beads the shear field in the bioreactor while molecules (e.g., nutrients) can be exchanged with the bulk of the medium with a mean diameter of 320 µm under GMP conditions at a rate of 5,200 beads/s, corresponding to 330 ml of or circulate (e.g., paracrine factors) within the bead. This may be particularly important for directing the differen-alginate/cell suspension per hour whereas rates of up to 10,000 beads/s are feasible (43) . Second, clustering of tiation of stem cells in serum-free media, in which cells are increasingly labile to shear (45) . smaller aggregates due to mixing in the spinner flask is avoided. We did not observe oversized aggregates,
The permeability of pLL-layered alginate beads can be controlled through parameters such as the incubation which can be detrimental for cell viability and directed commitment due to limitations in nutrient/factor trans-time for pLL coating and the number of pLL or alginate layers (23). The pLL-layered beads in this study were port. Prevention of excessive clumping also permits tighter control of the bioprocess. Third, the pLL layer not coated with extra layers of alginate, which may reduce the bead permeability. Capsules were sufficiently provides structural rigidity to low-concentration alginate beads and permits core liquefaction under mild condi-stable in the bioreactor since we did not observe any broken pLL-coated LC beads in any of the experimental tions, thus preserving the viability of cells. Within LC beads, cells form aggregates and grow more than in conditions we implemented. Beads in our experiments were permeable to a 106 kDa IgG-FITC. Others (3) solid capsules. The mechanical stability of the microcapsules makes possible the prolonged culture of cells showed the diffusion of 300 kDa compounds through pLL-coated alginate capsules. Most differentiation agents under continuous agitation (and induced shear) in a bio- such as growth factors have typically a lower molecular rior of LC capsules allows paracrine factors to circulate more easily, thus promoting cell differentiation. weight (e.g., activin A is a homodimer of ϳ13 kDa monomers) making the pLL-layered alginate matrix an
In our study, we chose to encapsulate hESCs (and mESCs) at 5 × 10 6 /ml of alginate solution because the ideal system for directing stem cell fate with physiologically relevant factors.
aggregates generated (after 1 day) were ϳ200 µm in diameter (Fig. 1G ). This is close to the average size To demonstrate this, mESCs encapsulated in pLLcoated LC beads were coaxed with BMP4 under serum-(ϳ210 µm), which was found to be optimal for cardiac induction of H9 cells in spinner flask cultures (35) . We free conditions both in static and bioreactor cultures. BMPs are secreted by the anterior mesoderm and layers acknowledge that the EB size should be considered along with other parameters impacting the differentia-adjacent to the embryonic heart (46). Deficiency in the expression of one BMP member is compensated by ov-tion outcome, such as the heterogeneity of the initial ESC population, hypoxia, and agents used for differenti-erexpression of other BMPs (14) and most likely not all BMPs are required for in vitro cardiogenic commitment ation. Nonetheless, the role of ESC aggregate size has not been explored in conjunction with differentiation of stem cells. We recognize that BMP4 alone is not sufficient to drive ESCs to mature functional cardiac cells.
protocols utilizing physiologically relevant stimuli in bioreactor cultures. In addition, it appears that the range However, the fractions of beating foci were higher in cultures treated with BMP4 than FBS, even after the of EB sizes resulting in optimal cardiogenic differentiation may depend on the ESC line used (9) . We also addition of RA to the latter. Moreover, BMP4 drives the cardiogenic differentiation of hESCs and cynomolgus seeded spinner flasks with 2 × 10 4 cells/ml, although it would interesting to investigate whether the differentia-monkey ESCs (18,52) besides mESCs. Hence, the serum-free protocol we reported here may be relevant for tion outcome depends on the initial concentration of ESCs seeded in the bioreactor. These issues can be tack-directing human stem cells to cardiac cells.
We also showed the differentiation of encapsulated led with a system combining stem cell encapsulation and bioreactor cultivation as described here. human ESCs in static and bioreactor cultures, albeit in serum-containing medium, which is typically used in Alginate microencapsulation technology has been employed for the culture of ESCs coaxed towards vari-coaxing hESC-derived EBs to heart cells (49) . Cells expressing cardiac markers emerged and organized into ous lineages, including insulin-producing cells (47) , bone cells (19) and hepatocytes (29) . We showed for the beating foci responding to chronotropic agents. Interestingly enough, the fractions of encapsulated hESC-derived first time that human and mouse ESCs in pLL-coated LC beads can be coaxed to cardiac (although possibly a Nkx2.5 + (and GATA4 + ) cells and mESC-derived Nkx2.5 + cells were higher in the bioreactor than in dish cultures. mix of atrial, ventricular, and nodal) cells when cultured in dishes or stirred-suspension vessels. Cell encapsula-The enhanced differentiation efficiency can be due in large part to the better transport characteristics in the tion was carried out by a widely used coaxial airflow droplet generation method. However, methods for mam-bioreactor, although further studies are warranted to address this issue. The improved cardiogenic commitment malian cell encapsulation are constantly improved to achieve smaller size beads (39) , better mechanical sta-of LC bead-encapsulated ESCs in the bioreactor may also explain the somewhat reduced expansion of human bility of capsules, lower shear exerted on the cell suspension during bead formation, versatility in the selec-and mouse cells compared to those cultured in dishes.
Yet, the difference in the percentage of Nkx2.5 + cells tion of biomaterials, and higher throughput. After differentiation of the encapsulated stem cells, the result-between static and suspension cultures was more pronounced for differentiating mESCs (Fig. 3C ) than ing progeny may be used directly (e.g., for implantation) or after its release and separation from the capsules. The hESCs (Fig. 7D ). This may reflect differences in species and/or differentiation protocols. hESCs were coaxed to latter requires the development of operations for downstream processing under mild conditions. Moreover, ef-cardiomyocyte-like cells in a nonspecific fashion (i.e., in serum-containing medium), whereas the differentia-ficient differentiation methods based on the use of defined media free of animal products will also be tion of mESCs was carried out with BMP4 and without serum. In addition, a higher fraction of Nkx2.5 + cells necessary for obtaining cells suitable for clinical applications. resulted from cells in LC compared to NLC beads. The more extensive proliferation of cells in the LC capsules
The simplicity, scalability, and cost-effectiveness of the method presented here in conjunction with the wide may have contributed to this finding. Another explanation may be based on the action of paracrine mecha-use of stirred-suspension bioreactors in industry warrant its further development for use in commercial settings. nisms, which are important for the differentiation of ESCs within EBs (4) . The increased fluidity in the inte-Mouse and human stem cells encapsulated in pLL- 
